Page 58 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 58
THURSDAY APRIL 23, 2015
Industry Satellite Symposia
7:00 - 8:00 Please refer to the Industry Section
Post Graduate Course - Metabolic Liver Disease Hall D
SCIENTIFIC PROGRAMME Chairs:
Jean-François Dufour, Switzerland
Vlad Ratziu, France
Herbert Tilg, Austria
Carcinogenesis and NAFLD
8:30 - 8:45 Q&A (QUESTIONS) case presentation
Heinz Zoller, Austria
8:45 - 9:05 Carcinogenesis and the spectrum of hepatic tumours in NASH
Augusto Villanueva, The United Kingdom
9:05 - 9:25 Liver cancer in NAFLD: magnitude of the problem
Jean-François Dufour, Switzerland
9:25 - 9:45 Do inflammation networks trigger NASH and drive its
progression?
Herbert Tilg, Austria
9:45 - 10:05 Impact of lifestyle on NASH (inclusive on HCC)
Ingrid Hickman, Australia
10:05 - 10:10 Q&A (ANSWERS)
10:10 - 10:30 Coffee Break
Progression of Liver Disease in NAFLD
10:30 - 10:45 Q&A (QUESTIONS) case presentation
Grace Dolman
10:45 - 11:05 Who are the NAFLD patients at risk of disease progression?
Chris Day, The United Kingdom
11:05 - 11:25 NAFLD diabetes and alcohol: is there a safe threshold?
Stefano Bellentani, Italy
58 The International Liver Congress™ 2015 • ILC Programme
Industry Satellite Symposia
7:00 - 8:00 Please refer to the Industry Section
Post Graduate Course - Metabolic Liver Disease Hall D
SCIENTIFIC PROGRAMME Chairs:
Jean-François Dufour, Switzerland
Vlad Ratziu, France
Herbert Tilg, Austria
Carcinogenesis and NAFLD
8:30 - 8:45 Q&A (QUESTIONS) case presentation
Heinz Zoller, Austria
8:45 - 9:05 Carcinogenesis and the spectrum of hepatic tumours in NASH
Augusto Villanueva, The United Kingdom
9:05 - 9:25 Liver cancer in NAFLD: magnitude of the problem
Jean-François Dufour, Switzerland
9:25 - 9:45 Do inflammation networks trigger NASH and drive its
progression?
Herbert Tilg, Austria
9:45 - 10:05 Impact of lifestyle on NASH (inclusive on HCC)
Ingrid Hickman, Australia
10:05 - 10:10 Q&A (ANSWERS)
10:10 - 10:30 Coffee Break
Progression of Liver Disease in NAFLD
10:30 - 10:45 Q&A (QUESTIONS) case presentation
Grace Dolman
10:45 - 11:05 Who are the NAFLD patients at risk of disease progression?
Chris Day, The United Kingdom
11:05 - 11:25 NAFLD diabetes and alcohol: is there a safe threshold?
Stefano Bellentani, Italy
58 The International Liver Congress™ 2015 • ILC Programme